Adding abemaciclib to standard endocrine therapy reduces the risk of death and recurrence in patients with breast cancer.
Ferring Pharmaceuticals today shared an oral presentation detailing microbiome restoration from the Phase 3b CDI-SCOPE study among patients with recurrent C. difficile (C. diff) infection (CDI) who ...
Everyday Health on MSN
‘Silent Killers’: 5 Cancers You Need to Know About
Learn about 5 hard-to-detect cancers: ovarian, cervical, inflammatory breast, pancreatic, and lung. Early detection and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback